Drugs / Lyophilized rabies vaccine for human use (Vero cells)
Lyophilized rabies vaccine for human use (Vero cells)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT05832073 Background | Apr → Dec 2023 | rabies | Changchun BCHT Biotechnology Co. | Unknown | No outcome recorded |
| Phase 2 | NCT06548139 Background | Jul 2024 → May 2025 overdue | rabies | Changchun BCHT Biotechnology Co. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyophilized rabies vaccine for human use (Vero cells) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06548139 ↗ |
| Modality | Vaccine | “Lyophilized rabies vaccine for human use (Vero cells)” NCT05832073 ↗ |